Effects of Low-load Resistance Training With Blood Flow Restriction in Patients With Achilles Tendinopathy
Launched by UNIVERSITY OF GRAN ROSARIO · Feb 4, 2022
Trial Information
Current as of May 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new exercise method called low-load resistance training with blood flow restriction (BFR-LLT) to see how it helps people with Achilles tendinopathy, which is a common and painful condition affecting the Achilles tendon in the lower leg. The aim is to compare how effective this new training method is compared to traditional high-load training, especially for those who may find it hard to do high-intensity exercises due to pain or other issues.
To join the study, participants need to be between 18 and 50 years old and have been experiencing pain in one Achilles tendon for more than three months. They should be able to attend in-person sessions two to three times a week for 12 weeks and must speak and read Spanish well enough to follow along with the study's instructions. Participants can expect to engage in specific exercise programs designed to improve their pain and function. It's important to note that individuals with certain conditions, such as previous surgery on the ankle or foot, recent heel pain, or high body mass index, may not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of unilateral MAT.
- • Achilles pain \> 3 months.
- • Age ranging between 18 to 50 years, both genders.
- • Read and speak Spanish well enough to provide informed consent and follow study instructions.
- • Can attend in-clinic treatments 2-3 x weekly for the next 12 weeks.
- Exclusion Criteria:
- • Any ankle or foot surgery.
- • History of Achilles rupture.
- • Heel pain in the last 3 months.
- • Systemic disorders/diseases.
- • History of deep venous thrombosis, hypertension or blood clotting disorder.
- • Body mass index \> 30kg/m2.
- • Self-report of pregnancy.
- • Drug use (local steroid injection or systemic fluoroquinolones).
- • Pain \< 2/10 of average pain on NPRS.
- • VISA A score \> 90%.
- • Unable to perform any of the exercises of the study.
About University Of Gran Rosario
The University of Gran Rosario is a distinguished academic institution committed to advancing medical research and education. As a clinical trial sponsor, it leverages its rich academic resources and expertise to facilitate innovative studies that contribute to the understanding and treatment of various health conditions. The university fosters collaboration between researchers, healthcare professionals, and industry partners, ensuring adherence to rigorous ethical standards and regulatory requirements. With a focus on improving patient outcomes and enhancing healthcare practices, the University of Gran Rosario is dedicated to driving scientific discovery and translating research findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rosario, Santa Fe, Argentina
Patients applied
Trial Officials
Gonzalo Elias, PT
Principal Investigator
University of Gran Rosario
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials